This book provides an in-depth analysis of Traditional Medical Knowledge (TMK) in China, focusing on its preservation, responsible use, and integration into modern intellectual property (IP) frameworks. It explores the unique challenges of protecting TMK within China's historical, cultural, and societal contexts, while also considering alternative regulatory mechanisms like Access and Benefit-Sharing (ABS) regimes and TMK databases. Through case studies such as the commercialization of Qinghao, the book examines the role of TMK in pharmaceutical innovation and critiques the applicability of Western IP systems to Chinese TMK. It also discusses the need for culturally sensitive legal reforms, offering practical insights for scholars, policymakers, and practitioners interested in IP law, traditional medicine, and cultural preservation. This work is enriched with comparative legal analyses and detailed examples, providing a clear understanding of the complexities surrounding TMK in China and its impact on both cultural heritage and innovation.

Dr. Nan Xia is a distinguished scholar and Assistant Professor at the Law School, China Jiliang University. Specializing in intellectual property law, Dr. Xia has made significant contributions to the field through innovative research, insightful publications, and engaging lectures. Throughout his career, he has focused on addressing complex issues in his area of expertise, offering novel solutions and methodologies. His work has received international recognition and has been published in leading academic journals and presented at conferences worldwide, establishing him as a respected figure in the field.